The government on Tuesday woke up to the concerns of thousands of cancer patients by announcing a new £50 million fund in a view to facilitate them with an effective access to cancer drugs.

Many cancer patients have been found to face a blatant denial for accessing cancer drugs, a practice deemed to be highly cost-effective by Nice (National Institute for Clinical Excellence).

The fund made available is revealed to be part of a £200 million fund not due to be announced until April.

The money is extended in a view to pay for the medicines of thousands of cancer survivors in England. These drugs can assist them to live for a few more months. However, the drugs were claimed to be highly expensive by watchdogs.

Expressing concern, academics at Leeds University insisted that the bill amount could easily touch £600 million.

Professor Mike Richards, the government’s cancer tsar, unveiled a report recently claiming that many developed countries across the world have surpassed UK in terms of their effective provision of cancers medicines to its patients.

However, he touted, “I honestly do not think that drug usage is linked to survival. Early diagnosis remains the most important factor”.